Optimization of management of patients with chronic heart failure taking into account cardiovascular functional status

Gafurdjanovna Mukhamedova Muyassar; Saidjanovna Narzullaeva Dildora

doi:10.30574/gscbps.2020.12.2.0263

Authors

Gafurdjanovna Mukhamedova Muyassar Cardiology department of Tashkent Postgraduate Medical Institute, Uzbekistan.
Saidjanovna Narzullaeva Dildora Internal Medicine department of Bukhara State Medical Institute, Bukhara, Uzbekistan

DOI:

https://doi.org/10.30574/gscbps.2020.12.2.0263

Keywords:

Chronic heart failure, Ischemic heart disease, Cardiovascular status

Abstract

This review article summarizes the reasons, pathophysiological mechanisms, possible clinical features, and the optimal management strategies of patients with chronic heart failure taking into account cardiovascular functional status. In addition, it shows current situation with chronic heart failure in the world, epidemiological status of the problem as well, risk factors contributing to the development of the disease.

Metrics

Metrics Loading ...

References

Alyavi A and Uzokov J. (2017). Treatment of stable angina pectoris: focus on the role of calcium antagonists and ACE inhibitors. Ont Health Technol Assess Ser, 15(9), 1-12.

Payziev D, Azizov SI, Uzokov JK and Iskhakov SA. (2020). P1003 New onset atrial fibrillation after stenting of the right coronary artery in patients with ischemic disease of the heart. EP Europace, 22(S1), 162-338.

Cabrera CC, Ekström M, Linde C, Persson H, Hage C, Eriksson MJ and Lyngå P. (2020). Increased iron absorption in patients with chronic heart failure and iron deficiency: Iron absorption in heart failure. J Card Fail. In press.

Radjabova DI, et al. (2018). The Features of Cytokine Status in Patients with Coronary Heart Disease. Hypertension & Vasc Biol Int J, 1(1), 000101.

Mamatkulov, KhA, Usarov MH, Uzokov ZhK, Arzieva, JB. (2015). Influence of interventional myocardial revascularization in patients with acute myocardial infarction without “q” wave. O 'zbekiston terapiya axborotnomasi, 2, 18.

Uzokov JK, Alyavi BA and Abdullaev AX. (2019). Assessment of the clopidogrel action with regard to CYP2C19 gene polymorphisms in patients with coronary artery disease after implantation of des stents. Euroasian Card J, S2, 309-309.

Belfiore A, Palmieri VO, Di Gennaro C, Settimo E, De Sario MG, Lattanzio S and Portincasa P. (2020). Long-term management of chronic heart failure patients in internal medicine. Internal and Emer Med, 15(1), 49-58.

Alyavi B, Uzokov JK, Abdullaev AX and Payziev DD. (2020). P427 Influence of ranolazine on cardioversion rate in patients with new onset atrial fibrillation and ischemic disease of the heart. EP Europace, 22(S1), 162-337.

Abdullaev AH, Alyavi BA, Iskhakov SHA, Uzakov ZhK, Ibabekova ShR, Yunusova LI, Azizov ShI. (2018). Some indicators of biochemical studies and echocardiography of patients with coronary heart disease who underwent stenting. In VI Eurasian Congress of Cardiology, 76.

Habib G, Lancellotti P, Erba PA, Sadeghpour A, Meshaal M, Sambola A and Cosyns B. (2019). The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry. Eur Heart J-Qual C Clin Out, 5(3), 202-207.

Alyavi BA et al. (2018). Clinical case of endovascular treatment of chronic cerebral arterial insufficiency in a patient with critical ischemia of the lower extremities. Bukovynskiy medical visnik, 22 (2), 86.

Abdullaev AKh et al. (2018). Some approaches to improve the effectiveness of the treatment of coronary heart disease. VI Eurasian Congress of Cardiology, 75-76.

Edelmann F, Knosalla C, Mörike K, Muth C, Prien P, Störk S and Group HFD. (2018). Chronic heart failure. Deut Ärz Inter, 115(8), 124.

Alyavi A, et al. (2018). Influence of Diet with Low Glycemic Index on Lipid Spectrum in Patients with Ischemic Disease of the Heart. Atherosclerosis Supplements, (32), 158.

Radjabova DI, Alyavi AL, Alyavi BA, Tulyaganova DK, Uzokov JK, Shodiev JD and Nuritdinova SK. (2018). The Features of Cytokine Status in Patients with Coronary Heart.

Alyavi BA et al. (2019). On an integrated approach to the treatment and rehabilitation of patients with ischemic heart disease. Eurasian Journal of Cardiology, S2, 154-154.

Abdullaev AH et al. (2019). Evaluation of the effectiveness of metabolic therapy in the complex treatment of coronary heart disease. Eurasian Journal of Cardiology, S2, 147-148.

Alyavi BA et al. (2019). The functional state of the liver in patients with ischemic heart disease. Eurasian Journal of Cardiology, S2, 155-155.

Uzokov J. (2020). Influence of abnormal lipid components in statin-naive young adults: Is there any gap?. Eur J Prev Card, 27(8), 868–869.

Lyutfullayevich AA, et al. (2017). Relationship between hemodynamic parametres and NPPA, NPPB, NPR3 genes polymorphism in patients with ischemic heart disease. International scientific review, 7(38).

Dick SA and Epelman S. (2018). Chronic heart failure and inflammation: what do we really know?. Circ Res, 119(1), 159-176.

Park JB. (2016). The Pulse of Asia 2016 Seoul, September 24-26, 2016, Seoul, Republic of Korea: Abstracts. Pulse, 4(2-3), 93.

Alyavi AL, et al. (2017).Predictors of contrast induced nephropathy in patients with metabolic syndrome. Eur Heart J, 38, 1283-1283.

Babaev M, et al. (2018). Influence of l-arginine aspartate on vascular markers in hypertensive patients with metabolic syndrome. Eur Heart J, 39, 495-495.

Alyavi BA et al. (2019). Influence of lipid-lowering and antiplatelet therapy on some biochemical and ultrasound parameters of patients with ischemic heart disease who underwent stenting. Cardiovascular Therapy and Prevention, 18 (S1), 12-13.

Abdullaev AH et al. (2019). Evaluation of the effectiveness of colstres in patients with coronary heart disease. Cardiovascular Therapy and Prevention, 18 (S1), 5-6.

Iskhakov S, et al. (2019). Comparative Analysis of The Inflammatory Biomarkers In Patients With Stable Coronary Artery Disease And Metabolic Syndrome. Atherosclerosis, 287, e171.

Lutfullayevich AA, et al. (2017). GW28-e0698 Telmisartan with amlodipine versus lisinopril with amlodipine on home blood pressure variability in patients with metabolic syndrome. J Amer Coll Card, 70(16), 138.

Sidalai RС and dr. (2015). β-adrenoblocators and myocardial infarction myocardial infarction. External Medicine Examiner, 2.

Usarov M, et al. (2016). Efficacy of Combination Therapy Using Nebivalol and Trimetazidine In Hypertensive Patients With Metabolic Syndrome And Stable Angina. J Hyperten, 34, e349.

Lutfullayevich AA, et al. (2017). Cardiovascular risk stratification and gender differences in hypertensive patients with metabolic syndrome. J Amer Col Card, 70(16), 138-139.

Mukhamedova M, et al. (2019). P120 Relationship between left ventricular global function index and cardiac systolic functions in patients with chronic ischemic disease of the heart and diabetes mellitus. Eur Heart J-Card Imag, 20(S3), 147, 008.

Ahmedov I, et al. (2016). Features of hyperreninemic aldosteronism in hypertension patients with metabolic syndrome. Eur J Prev Card, 23(1).

Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C and Oliver L. (2019). Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J, 40(39), 3222-3232.